Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume 30, Issue 1, Pages 48-56
Publisher
Springer Nature
Online
2015-09-29
DOI
10.1038/leu.2015.261
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries
- (2015) V S Hoffmann et al. LEUKEMIA
- Differences among young adults, adults and elderly chronic myeloid leukemia patients
- (2014) F. Castagnetti et al. ANNALS OF ONCOLOGY
- Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV
- (2013) Lida Kalmanti et al. ANNALS OF HEMATOLOGY
- European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
- (2013) M. Baccarani et al. BLOOD
- Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV
- (2013) Rüdiger Hehlmann et al. JOURNAL OF CLINICAL ONCOLOGY
- The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib
- (2013) V S Hoffmann et al. LEUKEMIA
- Model selection in competing risks regression
- (2013) Deborah Kuk et al. STATISTICS IN MEDICINE
- A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia
- (2012) J. P. Radich et al. BLOOD
- Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial
- (2012) Jorge E. Cortes et al. JOURNAL OF CLINICAL ONCOLOGY
- On Estimation in Relative Survival
- (2011) Maja Pohar Perme et al. BIOMETRICS
- Combination of pegylated IFN- 2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
- (2011) B. Simonsson et al. BLOOD
- Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score
- (2011) J. Hasford et al. BLOOD
- Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party
- (2011) G. Gugliotta et al. BLOOD
- Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia
- (2011) Rüdiger Hehlmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia
- (2011) M Pfirrmann et al. LEUKEMIA
- Regression modeling of competing risk using R: an in depth guide for clinicians
- (2010) L Scrucca et al. BONE MARROW TRANSPLANTATION
- Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a study of the Spanish PETHEMA group
- (2010) F. Cervantes et al. HAEMATOLOGICA
- Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia
- (2010) Claude Preudhomme et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
- (2010) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
- (2010) Giuseppe Saglio et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search